Table 1:
Demographics and clinical characteristics of all 243 patients treated with FAS
Characteristic | N=243 N (%) |
---|---|
Age, years | |
Median | 56 |
Interquartile range | 47–63 |
Sex | |
Male | 137 (56) |
Female | 106 (44) |
Tumor type | |
Nonfunctioning | 218 (90) |
Functioning | 25 (10) |
Genetic syndrome | |
Sporadic | 231 (95) |
Multiple endocrine neoplasia type 1 | 12 (5) |
Tumor status | |
Locally advanced | 20 (8) |
Metastatic | 223 (92) |
FAS line of therapy | |
First | 208 (86) |
Second or greater | 35 (14) |
Resection of the primary tumor | |
No | 191 (79) |
Yes | 52 (21) |
First post-FAS scan result, % (95% CI) | |
Complete or partial response | 41 % (95% CI: 36–48%) |